A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy
Adnan Kastrati, MD*,*,
Julinda Mehilli, MD*,
Stefan Nekolla, PhD
,
Hildegard Bollwein, MD
,
Stefan Martinoff, MD*,
Jürgen Pache, MD
,
Helmut Schühlen, MD*,
Melchior Seyfarth, MD
,
Meinrad Gawaz, MD*,
Franz-Josef Neumann, MD
,
Josef Dirschinger, MD
,
Markus Schwaiger, MD
,
Albert Schömig, MD*
STOPAMI-3 Study Investigators
* Deutsches Herzzentrum, Munich, Germany
1. Medizinische Klinik rechts der Isar, Munich, Germany
Klinik und Poliklinik für Nuklearmedizin rechts der Isar, Technische Universität, Munich, Germany

View larger version (74K):
[in a new window]
|
Figure 1 Scintigraphic and left ventricular (LV) angiographic images recorded in a 69-year-old patient treated with coronary artery stenting 16 h after onset of symptoms of acute anterior myocardial infarction. (A) Vertical long-axis view of 99m technetium sestamibi scintigraphy. (B) End-diastolic frame of LV angiography in 30° right-anterior oblique view. (C) End-systolic frame of LV angiography in 30° right-anterior oblique view.
|
|

View larger version (22K):
[in a new window]
|
Figure 2 Graph showing the salvage index achieved in various subsets and the differences in the salvage index between the stent group and the percutaneous transluminal coronary angioplasty (PTCA) group. Horizontal bars indicate the 95% confidence interval.
|
|

View larger version (15K):
[in a new window]
|
Figure 3 Six-month survival curves for patients in the stent group and those in the percutaneous transluminal coronary angioplasty (PTCA) group.
|
|
Copyright © 2004 by the American College of Cardiology Foundation.